Cite
APA Citation
Sato, K., Akamatsu, H., Murakami, E., Sasaki, S., Kanai, K., Hayata, A., Tokudome, N., Akamatsu, K., Koh, Y., Ueda, H., Nakanishi, M., & Yamamoto, N. (2018). corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71–74]. Lung cancer, 126, 230–231. http://access.bl.uk/ark:/81055/vdc_100074728872.0x000044